Status:
UNKNOWN
Pharmacogenetic Study for Topiramate-Induced Cognitive Dysfunction
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Cognitive Dysfunction
Eligibility:
All Genders
17-70 years
Brief Summary
Topiramate (TPM) is an antiepileptic drug with a unique mode of action that is often useful in patients refractory to other drugs. However its use is restricted by the high incidence of cognitive adve...
Eligibility Criteria
Inclusion
- adult (\>17 years old) patients with epilepsy or patients with migraine treated by topiramate
Exclusion
- allergy to topiramate
- abnormal liver or renal function
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00731900
Start Date
April 1 2007
End Date
December 1 2009
Last Update
August 11 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100